{"id":"W1989502045","doi":"10.4137/cmt.s3783","title":"Lapatinib, a Dual-Targeted Small Molecule Inhibitor of EGFR and HER2, in HER2-Amplified Breast Cancer: From Bench to Bedside","year":2011,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Lapatinib; Trastuzumab; Breast cancer; Cancer research; Medicine; Tyrosine kinase; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Metastatic breast cancer; Cancer; Targeted therapy; Pertuzumab; Letrozole; Oncology; Internal medicine; Receptor; Tamoxifen","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009217748,0.0004055147,0.001405459,0.0003318842,0.00005595083,0.00001046471,0.000308653,0.0004568688,0.0008153943],"category_scores_gemma":[0.0005369924,0.0002965606,0.0001325081,0.0007770206,0.0008615247,0.00005665349,0.0001965381,0.001057989,0.0000269038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001380629,"about_ca_system_score_gemma":0.000499358,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007467125,"about_ca_topic_score_gemma":0.002485818,"domain_scores_codex":[0.9956126,0.0004155079,0.001802917,0.0008333804,0.0007410267,0.0005946356],"domain_scores_gemma":[0.9966149,0.0009663487,0.0002994488,0.0008687962,0.0004891451,0.0007613144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007960469,0.0039113,0.7006438,0.000657806,0.001197645,0.0008598748,0.0279428,0.000003551856,0.0699002,0.0006806348,0.00316946,0.1830724],"study_design_scores_gemma":[0.01358773,0.006799127,0.9315073,0.003585053,0.0005789172,0.00006002181,0.00183486,0.0003526096,0.02355733,0.002594531,0.01480275,0.0007396999],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984028,0.003476724,0.00008578692,0.008040126,0.0007047638,0.001168256,0.00006831301,0.00006630378,0.002361701],"genre_scores_gemma":[0.9858797,0.002799896,0.00159343,0.008247524,0.001068418,0.0001039274,0.00003263604,0.0000894745,0.0001850102],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2308635,"threshold_uncertainty_score":0.9999487,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1881386438902378,"score_gpt":0.4205964844946525,"score_spread":0.2324578406044146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}